Scope Law advises Swiss biotech startup in negotiating a license agreement to out license a platform-technology developed by it for commercialization by the licensee together with venture capital investors.
top of page
Recent Posts
See AllScope Law advises Perovskia Solar AG , Aubonne, a spin-off from the Swiss Federal Laboratories for Materials Science and Technology (...
Scope Law advises Crearene AG , Frauenfeld, Switzerland on further equity financing. Crearene, an innovative medical technology company...
Scope Law acts as Swiss legal counsel to the shareholders of Pharma-Data S.A. (Greece) on its sale to Rosemont Pharmaceuticals Ltd....
bottom of page
Comments